Overview

Metoclopramide Use in Very Low Birth Weight Newborns

Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
During the first 7 days of life very small babies will receive the drug metoclopramide or a salt solution through an intravenous line. They will also begin to receive a very small amount of breast milk or formula within the first 72 hours of life, in addition toother nourishment that is provided by an intravenous line, according to standard hospital procedure. We think that the babies who receive the medication may reach full oral feeds than babies who receive the salt solution.
Phase:
Phase 4
Details
Lead Sponsor:
Lawson Health Research Institute
Treatments:
Metoclopramide